Vitanova Biomedical

About:

Vitanova Biomedical is an early-stage biotechnology company focused on delivering transformative cancer therapy.

Website: http://vitanovabiomedical.com

Top Investors: National Science Foundation, Texas A&M Innovation

Description:

Vitanova Biomedical is an early-stage biotechnology company focused on delivering transformative cancer therapy with the use of Light-Activated Intracellular Acidosis. The company aims to improve the lives of cancer patients and the professionals who care for them by providing cost-effective and efficacious cancer therapy that eliminates side effects. It was founded in 2015 by Matt Gdovin and Greg Espenhover in Kerrville, Texas in 2015.

Total Funding Amount:

$980000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Kerrville, Texas, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)VNBiomed.com

Founders:

Greg Espenhover, Matthew Gdovin

Number of Employees:

1-10

Last Funding Date:

2021-05-20

IPO Status:

Private

Industries:

© 2025 bioDAO.ai